1. Capsaicin enhances anti-proliferation efficacy of pirarubicin via activating TRPV1 and inhibiting PCNA nuclear translocation in 5637 cells
   LONG ZHENG et al, 2016 CrossRef
2. null
   Jamie R. Friedman et al, 2019 CrossRef
3. Anaphylactic shock due to intravesical administration of pirarubicin hydrochloride for the fifth time
   Koji Sakata et al, 2016, Journal of Clinical Anesthesia CrossRef
4. The effect of acyl chain length and saturation on the interactions of pirarubicin with phosphatidylethanolamines in 2D model urothelial cancer cell membranes
   Dorota Matyszewska et al, 2020, Journal of Molecular Liquids CrossRef
5. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
   O.A. El-Kawy et al, 2021, Applied Radiation and Isotopes CrossRef
6. Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study
   Noboru Sasaki et al, 2022, Front. Pharmacol. CrossRef
7. Comparison of the Efficacy of Postoperative Gemcitabine versus Pirarubicin Perfusion Chemotherapy for Non-Muscle Invasive Bladder Cancer
   文杰 万, 2023, ACM CrossRef
8. Homologous Targeting and Adhesion Abilities of Cellular Microvesicles for Enhanced Intravesical Therapy of Bladder Cancer
   Fan Qi et al, 2023, Advanced Therapeutics CrossRef